| 標題: |
A multicenter open-label phase 1 study evaluating the safety and tolerability of HMPL-306 in patients with locally advanced or metastatic solid tumors with IDH mutations. 一項多中心、開放標簽的I期研究︰評估HMPL-306治療伴有IDH突變的局部晚期或轉移性實體瘤患者的安全性和耐受性 |
| 主要作者: | Filip Janku, MD, MD Anderson Cancer Center |
| 會議環節: | 海報展示︰發展療法 – 分子靶向藥物和腫瘤生物學 |
| 摘要編號: | TPS3159 |